Skip to main content
Log in

Expression of BCRP gene in the normal lung tissue and lung cancer

  • Basic Investigations
  • Published:
Chinese Journal of Cancer Research

Abstract

Objective: To investigate the expression of novel multidrug resistance transporter (BCRP gene) from human MCF-7/AdrVp breast cancer cells in normal lung tissue and non-small lung cancer tissue. Methods: RNA was extracted immediately from fresh normal lung tissue and viable tumor tissue harvested from surgically resected specimens of non-small cell lung cancer patients. cDNA of BCRP gene was prepared by RT-PCR and was then amplified by PCR. cDNA products from those specimens were transferred to blotting membrane through electrophoresis and transferring technique and southern blot hybridization was eventually performed to detect the expression of BCRP gene. Results: RNA were extracted from 8 tumor tissue alone and 12 pairs of tumor tissue and normal lung tissue harvested from the same lung. Four patients’ RNA samples with poor quality due to degrading were discarded. cDNA products of BCRP gene were obtained by RT-PCR and were then amplified by PCR in the remain 16 patients’ RNA samples. Through southern blot hybridization, BCRP gene was found to be slightly expressed in various amounts in all normal lung tissue (10/10) and only in a half of tumor tissue samples (8/16). Conclusion: BCRP gene is slightly expressed in different amount in all normal lung tissue and only in a half of tumor tissue of non-small cell lung cancer patients. It is possible to induce it’s overexpression and to develop multidrug resistance during chemotherapy if using anthracycline anticancer drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Croop JM, Guild BC, Grosp, Housman DE. Genetics of multidrug resistance: Relationship of a cloned gene to the complete multidrug resistant phenotype [J]. Cancer Res 1987; 47:5982.

    PubMed  CAS  Google Scholar 

  2. Twentyman PR, Rhodes T, Rayner S. A comparison of rhodamine 123 accumulation and efflux in cells with p-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes [J]. Eur J Cancer 1994; 30A:1360.

    Article  PubMed  CAS  Google Scholar 

  3. Veneroni S, Zaffarom N, Daidone MG, et al. Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancers [J]. Eur J Cancers 1994; 30A:1002.

    Article  CAS  Google Scholar 

  4. Marquardt D, McCrone S, Center MS. Mechanisms of multidrug resistance in HL6O cells: detection of resistance-associated proteins with antibodies against synthetic peptides that correspond to the deduced sequence of P-glycoprotein [J]. Cancer Res 1990; 50:1426.

    PubMed  CAS  Google Scholar 

  5. Krishnamachary N, Center MS. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein [J]. Cancer Res 1993; 53:3658.

    PubMed  CAS  Google Scholar 

  6. Cole SPC, Bhardwaj G, Gerlach JH, et al. Over-expression of a transporter gene in a multidrug resistant human lung cancer cell line [J]. Science 1993; 258:1650.

    Article  Google Scholar 

  7. Center MS. Non-P-protein multidrug resistance in cell lines which are defective in the cellular accumulation of drug [J]. Cytotech 1993; 12:109.

    Article  CAS  Google Scholar 

  8. Chen YN, Mickley LA, Schwartz AM, et al. Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein [J]. J Biol Chem 1990; 265:10073.

    PubMed  CAS  Google Scholar 

  9. Doyel LA, Ross DD, Sridhara R, et al. Expression of a 95 kDa membrane protein is associated with low daunorubicin accumulation in leukaemic blast cells [J]. Br J Cancer 1995c; 71:52.

    Google Scholar 

  10. Lee JS, Scala S, Matsumoto Y, et al. Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression [J]. J Cellular Biochem 1997; 65:513.

    Article  CAS  Google Scholar 

  11. Doyle LA, Yang WD, Abruzzo LV, et al. A multidrug-resistance transporter from human MCF-7 breast cancer cells [J]. Proc Natl Acad Sci USA 1998; 95:15665.

    Article  PubMed  CAS  Google Scholar 

  12. Ross DD, Doyle LA, Schiffe CA, et al. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients [J]. Leukemia 1996; 10:48.

    PubMed  CAS  Google Scholar 

  13. Paul A, Bunn JR, Everett E, et al. An update on North American randomized studies in non-small cell lung cancer [J]. Seminars in Oncology 1998; 25(suppl 9):2.

    Google Scholar 

  14. Ronald B. Natale. Overview of current and future chemotherapeutic agents in non-small cell lung cancer [J]. Seminars in Oncology 1997; 24 (suppl 7):29.

    Google Scholar 

  15. Dillman RO, Seagren SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high dose radiation versus radiation alone in stage III non-small cell lung cancer [J]. N Engl J Med 1990; 323:940.

    Article  PubMed  CAS  Google Scholar 

  16. Dillman RO, Herndon J, Seagren SL, et al. Improved survival in stage III non-small cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial [J]. J Natl Cancer Inst 1996; 88:1210.

    Article  PubMed  CAS  Google Scholar 

  17. Thierry Le Chevalier. Adjuvant chemotherapy in Non-small cell lung cancer [J]. Seminars in Oncology 1998; 25 (suppl 9): 62.

    Google Scholar 

  18. Roth JA, Fossella F, Kamoski R, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIa non-small cell lung cancer [J]. J Natl Cancer Inst 1994; 86:673.

    Article  PubMed  CAS  Google Scholar 

  19. Cole SPC, Bhardwaj G, Gerlach JH, et al. Over-expression of a transporter gene in a multidrug-resistant human lung cancer cell line [J]. Science 1992; 258:1650.

    Article  PubMed  CAS  Google Scholar 

  20. Versantvoort CHM, Broxterman HJ, Pinedo HM, et al. Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression [J]. Cancer Research 1992; 52:17.

    PubMed  CAS  Google Scholar 

  21. Doyle LA, Ross DD, Ordonez JV, et al. An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein [J]. British I Cancer 1995; 72:535.

    CAS  Google Scholar 

  22. Molt R, Franke WW, Schiller DL. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells [J]. Cell 1982; 31:11.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mao You-sheng.

Additional information

Biography: MAO You-sheng (1963–), master degree, associate professor, Cancer Hospital & Institute, Chinese Academy of Medical Sciences, majors in cardiothoracic surgery and thoracic tumor.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mao, Ys., Doyle, A., Yang, W. et al. Expression of BCRP gene in the normal lung tissue and lung cancer. Chin. J. Cancer Res. 13, 22–26 (2001). https://doi.org/10.1007/s11670-001-0006-z

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11670-001-0006-z

Key words

CLC number

Navigation